kabutan

Immuno-Biological Laboratories Co., Ltd.(4570) Summary

4570
TSE Growth
Immuno-Biological Laboratories Co., Ltd.
1,450
JPY
+5
(+0.35%)
Mar 13, 3:30 pm JST
9.09
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
1,450.5
Mar 13, 11:57 pm JST
Summary Chart Historical News Financial Result
PER
50.9
PBR
7.66
Yield
0.41%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:02 am
1,415 JPY 8.89 USD
Previous Close Mar 12
1,445 JPY 9.08 USD
High Mar 13, 3:22 pm
1,453 JPY 9.11 USD
Low Mar 13, 9:02 am
1,415 JPY 8.88 USD
Volume
105,800
Trading Value
0.15B JPY 0.95M USD
VWAP
1429.88 JPY 8.97 USD
Minimum Trading Value
145,000 JPY 909 USD
Market Cap
0.01T JPY 0.08B USD
Number of Trades
509
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
3,115
1-Year High Dec 30, 2025
93,496
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 1,180,300
Feb 27, 2026 0 1,338,100
Feb 20, 2026 200 1,395,600 6978.00
Feb 13, 2026 0 1,413,500
Feb 6, 2026 0 1,329,100
Company Profile
Immuno-Biological Laboratories Co., Ltd. manufactures and sells research reagents and offers contract services. The silkworm development business has been suspended. The company has entered the cosmetics business.
Sector
Pharmaceuticals
Immuno-Biological Laboratories Co., Ltd. primarily manufactures and sells antibody-based research reagents, in vitro diagnostic pharmaceuticals, and raw materials for in vitro diagnostic pharmaceuticals. The company also develops pharmaceutical seeds utilizing antibody production technology and provides the lipoprotein profiling analysis service "LipoSEARCH". Additionally, the company offers contract services for mass production of proteins and antibodies using genetically modified silkworm technology. Furthermore, in the cosmetics sector, Immuno-Biological Laboratories Co., Ltd. focuses on developing and selling products containing silkworm-derived "NeoSilk-Human Collagen I".